BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26987717)

  • 1. A crucial role of Cys218 in configuring an unprecedented auto-inhibition form of MAP2K7.
    Sogabe Y; Hashimoto T; Matsumoto T; Kirii Y; Sawa M; Kinoshita T
    Biochem Biophys Res Commun; 2016 Apr; 473(2):476-81. PubMed ID: 26987717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5Z-7-Oxozeaenol covalently binds to MAP2K7 at Cys218 in an unprecedented manner.
    Sogabe Y; Matsumoto T; Hashimoto T; Kirii Y; Sawa M; Kinoshita T
    Bioorg Med Chem Lett; 2015 Feb; 25(3):593-6. PubMed ID: 25529738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution structure discloses the potential for allosteric regulation of mitogen-activated protein kinase kinase 7.
    Kinoshita T; Hashimoto T; Sogabe Y; Fukada H; Matsumoto T; Sawa M
    Biochem Biophys Res Commun; 2017 Nov; 493(1):313-317. PubMed ID: 28890347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for producing selective MAP2K7 inhibitors.
    Murakawa Y; Valter S; Barr H; London N; Kinoshita T
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127546. PubMed ID: 32931911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state.
    Matsumoto T; Kinoshita T; Matsuzaka H; Nakai R; Kirii Y; Yokota K; Tada T
    J Biochem; 2012 May; 151(5):541-9. PubMed ID: 22383536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal and solution structures disclose a putative transient state of mitogen-activated protein kinase kinase 4.
    Matsumoto T; Kinoshita T; Kirii Y; Tada T; Yamano A
    Biochem Biophys Res Commun; 2012 Aug; 425(2):195-200. PubMed ID: 22828509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and dynamics of the MKK7-JNK signaling complex.
    Kragelj J; Palencia A; Nanao MH; Maurin D; Bouvignies G; Blackledge M; Jensen MR
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3409-14. PubMed ID: 25737554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Covalent Pyrazolopyrimidine-MKK7 Complexes and a Report on a Unique DFG-in/Leu-in Conformation of Mitogen-Activated Protein Kinase Kinase 7 (MKK7).
    Wolle P; Engel J; Smith S; Goebel L; Hennes E; Lategahn J; Rauh D
    J Med Chem; 2019 Jun; 62(11):5541-5546. PubMed ID: 31083997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities.
    Schröder M; Tan L; Wang J; Liang Y; Gray NS; Knapp S; Chaikuad A
    Cell Chem Biol; 2020 Oct; 27(10):1285-1295.e4. PubMed ID: 32783966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.
    Narayana N; Cox S; Shaltiel S; Taylor SS; Xuong N
    Biochemistry; 1997 Apr; 36(15):4438-48. PubMed ID: 9109651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of the PKC-iota kinase domain in its ATP-bound and apo forms reveal defined structures of residues 533-551 in the C-terminal tail and their roles in ATP binding.
    Takimura T; Kamata K; Fukasawa K; Ohsawa H; Komatani H; Yoshizumi T; Takahashi I; Kotani H; Iwasawa Y
    Acta Crystallogr D Biol Crystallogr; 2010 May; 66(Pt 5):577-83. PubMed ID: 20445233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia.
    Winchester CL; Ohzeki H; Vouyiouklis DA; Thompson R; Penninger JM; Yamagami K; Norrie JD; Hunter R; Pratt JA; Morris BJ
    Hum Mol Genet; 2012 Nov; 21(22):4910-21. PubMed ID: 22899651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.
    Huang Y; Komoto J; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
    J Mol Biol; 2000 Apr; 298(1):149-62. PubMed ID: 10756111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of human mitogen-activated protein kinase kinase 7gamma1.
    Michael L; Swantek J; Robinson MJ
    Biochem Biophys Res Commun; 2006 Mar; 341(3):679-83. PubMed ID: 16442502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors.
    Fricker M; Lograsso P; Ellis S; Wilkie N; Hunt P; Pollack SJ
    Arch Biochem Biophys; 2005 Jun; 438(2):195-205. PubMed ID: 15907786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and biophysical characterization of the Syk activation switch.
    Grädler U; Schwarz D; Dresing V; Musil D; Bomke J; Frech M; Greiner H; Jäkel S; Rysiok T; Müller-Pompalla D; Wegener A
    J Mol Biol; 2013 Jan; 425(2):309-33. PubMed ID: 23154170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domain.
    Handa N; Takagi T; Saijo S; Kishishita S; Takaya D; Toyama M; Terada T; Shirouzu M; Suzuki A; Lee S; Yamauchi T; Okada-Iwabu M; Iwabu M; Kadowaki T; Minokoshi Y; Yokoyama S
    Acta Crystallogr D Biol Crystallogr; 2011 May; 67(Pt 5):480-7. PubMed ID: 21543851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active site mutants of Escherichia coli dethiobiotin synthetase: effects of mutations on enzyme catalytic and structural properties.
    Yang G; Sandalova T; Lohman K; Lindqvist Y; Rendina AR
    Biochemistry; 1997 Apr; 36(16):4751-60. PubMed ID: 9125495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
    Otto KB; Acharya SS; Robinson VL
    Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.